en
Ben Goldacre

Bad Pharma

Beri tahu saya ketika buku ditambahkan
Untuk membaca buku ini unggah file EPUB atau FB2 ke Bookmate. Bagaimana cara mengunggah buku?
Ben Goldacre puts the $600bn global pharmaceutical industry under the microscope. What he reveals is a fascinating, terrifying mess. ***Now updated with the latest government responses to the book***
Doctors and patients need good scientific evidence to make informed decisions. But instead, companies run bad trials on their own drugs, which distort and exaggerate the benefits by design. When these trials produce unflattering results, the data is simply buried. All of this is perfectly legal. In fact, even government regulators withhold vitally important data from the people who need it most. Doctors and patient groups have stood by too, and failed to protect us. Instead, they take money and favours, in a world so fractured that medics and nurses are now educated by the drugs industry.
The result: patients are harmed in huge numbers.
Ben Goldacre is Britain’s finest writer on the science behind medicine, and ‘Bad Pharma’ is the book that finally prompted Parliament to ask why all trial results aren’t made publicly available — this edition has been updated with the latest news from the select committee hearings. Let the witty and indefatigable Goldacre show you how medicine went wrong, and what you can do to mend it.
Buku ini saat ini tidak tersedia
557 halaman cetak
Tahun publikasi
2012
Sudahkah Anda membacanya? Bagaimanakah menurut Anda?
👍👎

Kesan

  • elleveldamembagikan kesan6 tahun yang lalu

    Great book that chages completely the notion of a modern medicine

Kutipan

  • nitrushinamembuat kutipan7 tahun yang lalu
    It feels as if some people, perhaps, view research as a game, where the idea is to get away with as much as you can, rather than to conduct fair tests of the treatments we use.
  • nitrushinamembuat kutipan7 tahun yang lalu
    eighteen of the twenty-nine industry-funded trials presented a conclusion in the abstract that misrepresented the main outcome measure. All of the nonindustry-funded studies were fine
  • nitrushinamembuat kutipan8 tahun yang lalu
    the CCSG trial found that aspirin was effective at preventing stroke and death in men, but not in women;30 as a result, women were under-treated for a decade, until further trials and overviews showed a benefit.

Di rak buku

fb2epub
Seret dan letakkan file Anda (maksimal 5 sekaligus)